shipment_ID,catalog_ID,Formula,stereochemistry,sample_MW,purity,PO,Salt_Name,Salt_ratio,MW_salt,volume(uL),concentration(mM),plate_ID,well,SMILES,Name,Batch ID,"Amount, mg (left)"
MAT-POS-c88128cb-4,Z5367986313,C23H24ClN3O3S,Racemic or presumed racemic or meso,457.972,100,COVID-19,,,0,40,20,1178796-Y40-86,03_A,CC(C)CN1CC(C)(C(=O)NC=2C=NC=C3C=CC=CC23)C=4C=C(Cl)C=CC4S1(=O)=O,"6-chloro-N-(isoquinolin-4-yl)-4-methyl-2-(2-methylpropyl)-1,1-dioxo-3,4-dihydro-2H-1??,2-benzothiazine-4-carboxamide",H3608201,24.9
LUO-POS-868e8996-9,Z5442717982,C26H21ClN4O4S,Single unknown enantiomer,520.987,100,COVID-19,,,0,40,20,1178796-Y40-86,03_B,"ClC=1C=CC=2CN(C[C@]3(CC(=O)N(C3=O)C=4C=NC=C5C=CC=CC45)C2C1)S(=O)(=O)CC6(CC6)C#N |o1:8,r|","rel-1-({[(4R)-6-chloro-1'-(isoquinolin-4-yl)-2',5'-dioxo-2,3-dihydro-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2-yl]sulfonyl}methyl)cyclopropane-1-carbonitrile",H3622139,45.2
LUO-POS-868e8996-10,Z5442717985,C26H21ClN4O4S,Single unknown enantiomer,520.987,100,COVID-19,,,0,40,20,1178796-Y40-86,03_C,"ClC=1C=CC=2CN(C[C@@]3(CC(=O)N(C3=O)C=4C=NC=C5C=CC=CC45)C2C1)S(=O)(=O)CC6(CC6)C#N |o1:8,r|","rel-1-({[(4R)-6-chloro-1'-(isoquinolin-4-yl)-2',5'-dioxo-2,3-dihydro-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2-yl]sulfonyl}methyl)cyclopropane-1-carbonitrile",H3622140,43.5
MIK-ENA-5d9157e9-2,Z5461592593,C26H23ClN4O3S,Single unknown enantiomer,507.003,100,COVID-19,,,0,40,20,1178796-Y40-86,03_D,"ClC=1C=CC=2CN(C[C@@]3(CCN(C3=O)C=4C=NC=C5C=CC=CC45)C2C1)S(=O)(=O)CC6(CC6)C#N |o1:8,r|","rel-1-({[(4R)-6-chloro-1'-(isoquinolin-4-yl)-2'-oxo-2,3-dihydro-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2-yl]sulfonyl}methyl)cyclopropane-1-carbonitrile",H3629679,46.5
MIK-ENA-5d9157e9-1,Z5461592587,C26H23ClN4O3S,Single unknown enantiomer,507.003,100,COVID-19,,,0,40,20,1178796-Y40-86,03_E,"ClC=1C=CC=2CN(C[C@]3(CCN(C3=O)C=4C=NC=C5C=CC=CC45)C2C1)S(=O)(=O)CC6(CC6)C#N |o1:8,r|","rel-1-({[(4R)-6-chloro-1'-(isoquinolin-4-yl)-2'-oxo-2,3-dihydro-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2-yl]sulfonyl}methyl)cyclopropane-1-carbonitrile",H3629678,45.9
